Why Eli Lilly, Novo Nordisk, and Viking Therapeutics Stocks All Popped TodayThe Motley Fool • 04/14/25
Viking Therapeutics, Down 40%, Just Reached a New Milestone. Is the Stock a Buy Now?The Motley Fool • 04/02/25
Viking Therapeutics, Inc. (VKTX) Stock Slides as Market Rises: Facts to Know Before You TradeZacks Investment Research • 04/01/25
VKTX Finishes Enrolment in Mid-Stage Study on Oral Weight-Loss DrugZacks Investment Research • 03/27/25
Viking Therapeutics Skids Despite 'Rapid' Enrollment In Obesity Pill StudyInvestors Business Daily • 03/26/25
Viking Therapeutics Announces Completion of Enrollment in Phase 2 VENTURE-Oral Dosing Trial of VK2735 Tablet Formulation in Patients with ObesityPRNewsWire • 03/26/25
Viking Therapeutics, Inc. (VKTX) Rises But Trails Market: What Investors Should KnowZacks Investment Research • 03/24/25
Down 65% From Its 52-Week High, Is Viking Therapeutics Stock a Bargain Buy?The Motley Fool • 03/19/25
Why Viking Therapeutics and Roche Holdings Popped Today, but Novo Nordisk Stock DroppedThe Motley Fool • 03/12/25
Viking Therapeutics' new contract is a game changer. Here's how much money it could bring in.Market Watch • 03/12/25
VKTX Inks Manufacturing Deal With CordenPharma for Obesity Drug SupplyZacks Investment Research • 03/12/25
Viking Therapeutics Just Inked A $150 Million Manufacturing Deal. Here's Why Shares Crumbled.Investors Business Daily • 03/11/25